Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Work In Process (2016 - 2018)

Lifecore Biomedical, Inc. \De\ has reported Work In Process over the past 7 years, most recently at $3.1 million for Q4 2018.

  • Quarterly results put Work In Process at $3.1 million for Q4 2018, down 34.24% from a year ago — trailing twelve months through Nov 2018 was $3.1 million (down 34.24% YoY), and the annual figure for FY2018 was $3.7 million, up 6.53%.
  • Work In Process for Q4 2018 was $3.1 million at Lifecore Biomedical, Inc. \De\, down from $3.1 million in the prior quarter.
  • Over the last five years, Work In Process for LFCR hit a ceiling of $13.0 million in Q4 2016 and a floor of $1.9 million in Q2 2015.
  • Median Work In Process over the past 5 years was $3.3 million (2014), compared with a mean of $3.8 million.
  • Biggest five-year swings in Work In Process: soared 265.69% in 2016 and later crashed 63.95% in 2017.
  • Lifecore Biomedical, Inc. \De\'s Work In Process stood at $4.0 million in 2014, then fell by 11.86% to $3.6 million in 2015, then soared by 265.69% to $13.0 million in 2016, then crashed by 63.95% to $4.7 million in 2017, then tumbled by 34.24% to $3.1 million in 2018.
  • The last three reported values for Work In Process were $3.1 million (Q4 2018), $3.1 million (Q3 2018), and $3.7 million (Q2 2018) per Business Quant data.